Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Genedrive (GDR)

Price 5.00p on 29-02-2024 at 17:30:04
Change 0.25p 5.26%
Buy 5.25p
Sell 4.75p
Buy / Sell GDR Shares
Last Trade: Sell 102,899.00 at 4.95p
Day's Volume: 2,334,210
Last Close: 5.00p
Open: 4.75p
ISIN: GB00B1VKB244
Day's Range 4.75p - 5.50p
52wk Range: 4.25p - 45.50p
Market Capitalisation: £7m
VWAP: 5.14339p
Shares in Issue: 134m

Recent Trades History Genedrive (GDR)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 102,899 4.95p Ordinary
16:29:10 - 29-Feb-24
Buy* 40,000 5.24p Ordinary
16:25:57 - 29-Feb-24
Buy* 19,140 5.175p Ordinary
16:16:37 - 29-Feb-24
Buy* 8,952 5.175p Ordinary
15:51:53 - 29-Feb-24
Buy* 2,121 5.175p Ordinary
15:18:00 - 29-Feb-24
Sell* 24,689 4.8806p Ordinary
15:14:39 - 29-Feb-24
Buy* 5,000 5.18p Ordinary
15:10:30 - 29-Feb-24
Buy* 2,606 5.18p Ordinary
14:54:11 - 29-Feb-24
Buy* 7,491 5.18p Ordinary
13:26:00 - 29-Feb-24
Buy* 45,000 5.1668p Ordinary
12:50:42 - 29-Feb-24

Share Price History for Genedrive

Time period:
to
Date Open High Low Close Volume

Share News for Genedrive

TRADING UPDATES: Coro seals sale terms, Powerhouse makes good progress

19th Feb 2024 18:57

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

LONDON BRIEFING: MoneySupermarket credits Insurance for growth in 2023

19th Feb 2024 07:49

(Alliance News) - Stocks in London are set to fall at Monday's open, as concerns over US inflation trends curb risk appetite, and damp hopes of interest rate cuts from the Federal Reserve. Read More

IN BRIEF: Genedrive draws down GBP600,000 on prepayment facility

2nd Jan 2024 10:57

Genedrive PLC - Manchester, England-based molecular diagnostics company - Draws down GBP600,000 on its GBP5 million equity prepayment facility. In March last year, Genedrive agreed the GBP5 million equity prepayment facility with Riverfort Global Opportunities PCC Ltd. At the time it said that proceeds would be used towards the commercialisation of the antibiotic-induced hearing loss test, Genedrive MT-RNR1 ID Kit, and enhancing the Genedrive platform as well as providing additional working capital. Read More

UK shareholder meetings calendar - next 7 days

22nd Dec 2023 15:50

Read More

AIM WINNERS & LOSERS: Genedrive shares jump on orders

20th Dec 2023 11:07

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday. Read More

FTSE 100 Latest
Value7,630.02
Change5.04

Login to your account

Forgot Password?

Not Registered